
Link to Post on X – x.com/nntaleb/status/2011565701233066196
.org (UNOFFICIAL news site)

Link to Post on X – x.com/nntaleb/status/2011565701233066196
Link to Post on X – x.com/nntaleb/status/2003842691638116668

Abstract: risk factors for LDL/ApoB underestimate the risk factor for Lp(a) positive subjects and overestimate for Lp(a) negative ones, a case of base-rate fallacy.
I am just using basic probabilistic logic here.Risks factors for ASCVD from LDL (or ApoB) levels are computed for a general population which includes people with low and high Lp(a) levels. Now if having a high Lp(a) increases the cardiac risk over the baseline (up to 2-3 times!) and the proportion of subjects with high Lp(a) is between 15 and 28% of the population, then, necessarily, those with low Lp(a) will have, for a given level of LDL, a considerably lower risk and many might be treated unnecessarily.
The risk factor for nonLp(a) can be ~ 30% lower! Statins don’t come for free. There are hidden and less hidden side effects.
Continue reading on Substack – open.substack.com/pub/nntaleb/p/medical-mistakes-with-probability-284

Link to Post on X – https://x.com/nntaleb/status/1982121385594953828
Amazon Link – https://www.amazon.com/dp/B0FXPWYL9P/

Link to Post on X – x.com/nntaleb/status/1979651428038672799
Emi Gal, founder and CEO of Ezra, sat down with Nassim Taleb to talk about cancer, heart disease, full body MRIs, and more. The conversation covers why Nassim gets full body MRIs, the legitimate concerns around incidental findings, and what the data actually says about early cancer detection.